Dec 20, 2017, 07:00 ET
HOUSTON, Dec. 20, 2017 /CNW/ -- Nobilis Health Corp. (NYSE American: HLTH) ("Nobilis" or the "Company") today announced it has commenced the application process to list its common shares on the Aequitas NEO Exchange ("NEO") in Canada. Subject to regulatory approvals, Nobilis expects its common shares to be available for trading on NEO in early 2018.
"We believe that shareholder protection and value generation must lead our decision-making process in determining where to list Nobilis stock," stated Harry Fleming, Nobilis' CEO and Chairman of the Board. "What convinced us to come back to Canada was NEO's focus on liquidity, their investor communication services and the streamlined disclosure-based listing model, coupled with their unwavering dedication to meeting the needs of public companies and investors. We are also looking forward to the stabilizing role that NEO's dedicated market makers provide to the exchange. Our Canadian shareholders want this and we are convinced that a listing on NEO will benefit them as well as our global shareholder base."
"A company like Nobilis looking to come back to the Canadian capital markets through a dual listing, based on how we approach the stock exchange business, is very rewarding," added Jos Schmitt, President and Chief Executive Officer, NEO. "This is a leading US healthcare company, who generated over USD $285 million in revenue from numerous locations and partnerships across the US in 2016. They recognize the benefits the Canadian capital markets can bring to international companies. We recognize the opportunities international companies can bring to Canadian investors and the Canadian economy as a whole."
About Nobilis Health Corp.
Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company, with 31 locations across Texas and Arizona, including 5 hospitals, 13 ambulatory surgery centers, and 13 multi-specialty clinics. In addition, Nobilis partners with 36 facilities across the country. Marketing nine independent brands, Nobilis deploys a unique patient acquisition strategy driven by proprietary, direct-to-consumer marketing technology, focusing on a specified set of procedures that are performed at its facilities by local physicians. Nobilis' business model connects patients with physicians to deliver the highest quality healthcare while enhancing physician practices within the Nobilis network.
Vice President, Investor Relations
SOURCE Nobilis Health Corp.
Share this article